Corrigendum to “Analysis of Central Nervous System Efficacy in the J-Alex Study of Alectinib Versus Crizotinib in ALK-positive Non-Small-Cell Lung Cancer” [Lung Cancer 121 (July) (2018) Pages 37–40]

Lung Cancer - Netherlands

doi 10.1016/j.lungcan.2019.04.012